Republican and Democratic members on the House Energy and Commerce Committee questioned whether the FDA's criminal investigators are effective at blocking illegal drugs, including unapproved opioids, at US ports of entry; public health officials worry proposed HHS changes to move family planning funding toward groups that may not provide reproductive health and sexual health services will cripple other federal efforts to curb a rise in sexually transmitted diseases; leaders of a now-shelved, controversial study examining whether moderate drinking is beneficial for human health may have violated federal law.
Republican and Democratic members on the House Energy and Commerce Committee questioned whether the FDA's criminal investigators are doing enough to stop illegal drugs, including unapproved opioids, at US ports of entry, Reuters reported. Republican Chairman Greg Walden and leading Democrat Frank Pallone wrote to FDA Commissioner Scott Gottlieb, asking the agency to provide statistical data about the cases being generated through the port of entry initiative and its prosecution track record by June 22. The FDA's Office of Criminal Investigations has been under scrutiny after Reuters published articles in 2016 about the office’s approach to criminal investigations.Proposed HHS changes to move family planning funding toward groups that may not provide reproductive health and sexual health services and away from organizations that provide abortions could cripple other federal efforts to curb an explosion in sexually transmitted diseases (STDs), some public health officials told Kaiser Health News. If rules are adopted in their current form, Title X services would have to be physically and financially separate from abortion services. Title X grants fund family planning, STD screening, and breast and cervical cancer screening at nearly 4000 sites nationwide. Fewer funds would mean fewer resources available for STD screening, treatment, and outreach.
Leaders of a now-shelved controversial study examining whether moderate drinking is beneficial for human health may have violated federal law, STAT news reported. Public health researcher Michael Siegel, MD, of Boston University, said the federal officials soliciting funding for it from alcohol beverage makers failed to seek a form of regulatory approval from the FDA intended to protect study participants and ensure they understand the possible health risks of the research. The hospital whose physician designed the trial said it was their understanding that the regulatory approval, known as an investigational new drug application, was not required.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More